Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 28, 2024; 30(36): 4021-4024
Published online Sep 28, 2024. doi: 10.3748/wjg.v30.i36.4021
Published online Sep 28, 2024. doi: 10.3748/wjg.v30.i36.4021
Redefining hemorrhoid therapy with endoscopic polidocanol foam sclerobanding
Asad Gul Rao, Department of Clinical Medicine, Dow Medical College, Karachi 74200, Pakistan
Abdulqadir J Nashwan, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar
Author contributions: Rao AG and Nashwan AJ wrote the draft and critically reviewed the literature.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Abdulqadir J Nashwan, MSc, PhD, Research Scientist, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa
Received: July 4, 2024
Revised: August 13, 2024
Accepted: September 3, 2024
Published online: September 28, 2024
Processing time: 77 Days and 13.1 Hours
Revised: August 13, 2024
Accepted: September 3, 2024
Published online: September 28, 2024
Processing time: 77 Days and 13.1 Hours
Core Tip
Core Tip: This editorial highlights the groundbreaking study by Qu et al, which reveals that endoscopic polidocanol foam sclerobanding effectively reduces recurrence and post-procedural pain in grade II and III internal hemorrhoids compared to the traditional endoscopic rubber band ligation. Despite multiple limitations, such as a shorter follow-up period and potential subjective bias, the trial reflects profound clinical implications while suggesting additional research and innovative approaches to treatment.